News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.

Who is Who: Paul Peter Tak

https://feature.marquiswhoswho.com/WSJ_Tak_Paul_April23_2026

Leading Beyond the Lab: Viral Immunotherapy of Cancer

Developing Novel Viral Immunotherapies To Improve Cancer Outcomes

Marquis Who’s Who Honors Paul Peter Tak, MD, PhD, FMedSci for Expertise in Medicine and Research

https://www.24-7pressrelease.com/press-release/528367/marquis-whos-who-honors-paul-peter-tak-md-phd-fmedsci-for-expertise-in-medicine-and-research

ASCO 2025: Candel CEO shares Phase 3 prostate cancer data on off-the-shelf immunotherapy.

At the 2025 ASCO Annual Meeting in Chicago (May 30–June 3), Candel Therapeutics presented the results from its pivotal Phase 3 trial of CAN‑2409 (aglatimagene besadenovec) combined with valacyc…